Cosmo Pharmaceuticals N.V.
↗Dublin, Ireland
Cosmo Pharmaceuticals (recently rebranded as Cosmo Health) is a specialty pharmaceutical and MedTech company focused on developing and commercializing innovative products for gastrointestinal (GI) disorders, dermatology, and AI-enhanced endoscopy. The company is a global leader in AI-powered healthcare, notably through its GI Genius™ platform, which uses artificial intelligence to assist in the detection of colorectal lesions during colonoscopy.
Headquartered in Dublin, Ireland, Cosmo operates with a unique business model that combines internal R&D, contract development and manufacturing (CDMO), and strategic partnerships with global leaders like Medtronic and Sun Pharma. The company is currently in a 'Scale Up' phase, leveraging its Vision 2030 strategy to expand its AI MedTech footprint while advancing a late-stage dermatology pipeline, including a potential breakthrough treatment for male-pattern hair loss.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Pharmaceuticals
Sub-Industry:Gastroenterology, Dermatology, MedTech AI
SIZE & FINANCIALS
Employees:201-500
Revenue:$250M-$300M
Founded:1997
Ownership:public
Status:operating
FUNDING
Stage:Post-IPO
Investors:Mauro Ajani (Founder), Dievini Hopp BioTech, Invision
STOCK
Exchange:SIX Swiss Exchange
Ticker:COPN
Market Cap:$1.1B
PIPELINE
Stage:Commercial
Lead Drug Stage:Phase 3 (Breezula)
Modalities:Small molecule, Topical therapeutics, AI-Software as a Medical Device (SaMD), Medical Devices
Active Trials:5
Trial Phases:Phase 1: 1 | Phase 2: 2 | Phase 3: 2
FDA Approvals:4
EMA Approvals:3
CORPORATE STRUCTURE
Subsidiaries:Cosmo Intelligent Medical Devices, Cassiopea (Acquired/Merged), Cosmo Technologies Ltd
Key Partnerships:Medtronic (Global distribution of GI Genius), Sun Pharma (Winlevi commercialization), Bausch Health/Salix (Aemcolo), NVIDIA (AI hardware for GI Genius)
COMPETITION
Position:Leader
Competitors:Galderma, LEO Pharma, Bausch Health, Iterum Therapeutics, Iterative Health (AI competitor)
LEADERSHIP
Key Executives:
Giovanni Di Napoli - CEO
Svetlana Sigalova - CFO
Alessandro Della Chà - Chairman
Scientific Founders:Mauro Ajani
Board Members:Mauro Ajani, Alessandro Della Chà, Silvana Perretta, John O'Dea
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Cosmo Pharmaceuticals N.V.. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.